![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF (STB)
Has Durable Efficacy and Differentiated Safety Compared to Atazanavir Boosted by Ritonavir Plus Emtricitabine/Tenofovir DF in Treatment-naïve HIV-1 Infected Patients: Week 144 Results
|
|
|
Reported by Jules Levin
14th European AIDS Conference
October 16-19, 2013, Brussels, Belgium
N Clumeck1, J-M Molina2, K Henry3, J Gathe4, JK Rockstroh5, E DeJesus6,
X Wei7, K White7, M Fordyce7, MS Rhee7, J Szwarcberg7
1St Pierre University Hospital, Brussels, Belgium; 2Saint Louis Hospital, Paris, France; 3Hennepin County Medical Center, Minneapolis, MN, US; 4Therapeutic Concepts P.A., Houston, TX, US; 5University of Bonn, Bonn, Germany; 6Orlando Immunology Center, Orlando, FL, US; 7Gilead Sciences, Foster City, CA, US
![EACS1.gif](../images/101813/101813-2/EACS1.gif)
![EACS2.gif](../images/101813/101813-2/EACS2.gif)
![EACS3.gif](../images/101813/101813-2/EACS3.gif)
![EACS4.gif](../images/101813/101813-2/EACS4.gif)
![EACS5.gif](../images/101813/101813-2/EACS5.gif)
![EACS6.gif](../images/101813/101813-2/EACS6.gif)
![EACS7.gif](../images/101813/101813-2/EACS7.gif)
![EACS8.gif](../images/101813/101813-2/EACS8.gif)
![EACS9.gif](../images/101813/101813-2/EACS9.gif)
![EACS10.gif](../images/101813/101813-2/EACS10.gif)
![EACS11.gif](../images/101813/101813-2/EACS11.gif)
![EACS12.gif](../images/101813/101813-2/EACS12.gif)
![EACS13.gif](../images/101813/101813-2/EACS13.gif)
![EACS14.gif](../images/101813/101813-2/EACS14.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|